2:05 PM
 | 
Oct 24, 2018
 |  BC Extra  |  Financial News

Innovent raises $421M in Hong Kong IPO

Cancer and autoimmune company Innovent Biologics Inc. (HKSE:1801) priced its IPO on the Hong Kong stock exchange, raising HK$3.3 billion ($421 million), according to a source close to the deal who asked not to be named.

Innovent sold 236.4 million shares at HK$13.98, near the top of its proposed...

Read the full 229 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >